NM_001034853.2:c.2411G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001034853.2(RPGR):​c.2411G>A​(p.Arg804Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00152 in 1,041,819 control chromosomes in the GnomAD database, including 26 homozygotes. There are 334 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★★).

Frequency

Genomes: 𝑓 0.0079 ( 9 hom., 37 hem., cov: 8)
Exomes 𝑓: 0.0012 ( 17 hom. 297 hem. )

Consequence

RPGR
NM_001034853.2 missense

Scores

12

Clinical Significance

Benign reviewed by expert panel B:5

Conservation

PhyloP100: -1.17

Publications

0 publications found
Variant links:
Genes affected
RPGR (HGNC:10295): (retinitis pigmentosa GTPase regulator) This gene encodes a protein with a series of six RCC1-like domains (RLDs), characteristic of the highly conserved guanine nucleotide exchange factors. The encoded protein is found in the Golgi body and interacts with RPGRIP1. This protein localizes to the outer segment of rod photoreceptors and is essential for their viability. Mutations in this gene have been associated with X-linked retinitis pigmentosa (XLRP). Multiple alternatively spliced transcript variants that encode different isoforms of this gene have been reported, but the full-length natures of only some have been determined. [provided by RefSeq, Dec 2008]
RPGR Gene-Disease associations (from GenCC):
  • retinitis pigmentosa 3
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • RPGR-related retinopathy
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • primary ciliary dyskinesia-retinitis pigmentosa syndrome
    Inheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • cone-rod dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • macular degeneration, X-linked atrophic
    Inheritance: XL Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0029108226).
BP6
Variant X-38286588-C-T is Benign according to our data. Variant chrX-38286588-C-T is described in ClinVar as Benign. ClinVar VariationId is 446001.Status of the report is reviewed_by_expert_panel, 3 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00789 (376/47676) while in subpopulation AFR AF = 0.0305 (353/11571). AF 95% confidence interval is 0.0279. There are 9 homozygotes in GnomAd4. There are 37 alleles in the male GnomAd4 subpopulation. Median coverage is 8. This position passed quality control check.
BS2
High AC in GnomAd4 at 376 XL,AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001034853.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RPGR
NM_001034853.2
MANE Select
c.2411G>Ap.Arg804Lys
missense
Exon 15 of 15NP_001030025.1
RPGR
NM_000328.3
c.1905+506G>A
intron
N/ANP_000319.1
RPGR
NM_001367245.1
c.1902+506G>A
intron
N/ANP_001354174.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RPGR
ENST00000645032.1
MANE Select
c.2411G>Ap.Arg804Lys
missense
Exon 15 of 15ENSP00000495537.1
ENSG00000250349
ENST00000465127.1
TSL:5
c.172-379533C>T
intron
N/AENSP00000417050.1
RPGR
ENST00000339363.7
TSL:5
c.2520+506G>A
intron
N/AENSP00000343671.3

Frequencies

GnomAD3 genomes
AF:
0.00789
AC:
376
AN:
47655
Hom.:
9
Cov.:
8
show subpopulations
Gnomad AFR
AF:
0.0305
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00384
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000160
Gnomad OTH
AF:
0.00467
GnomAD2 exomes
AF:
0.00349
AC:
352
AN:
100892
AF XY:
0.00219
show subpopulations
Gnomad AFR exome
AF:
0.0424
Gnomad AMR exome
AF:
0.00301
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000535
Gnomad OTH exome
AF:
0.00241
GnomAD4 exome
AF:
0.00122
AC:
1212
AN:
994143
Hom.:
17
Cov.:
33
AF XY:
0.000965
AC XY:
297
AN XY:
307641
show subpopulations
African (AFR)
AF:
0.0412
AC:
953
AN:
23111
American (AMR)
AF:
0.00345
AC:
86
AN:
24900
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
16677
East Asian (EAS)
AF:
0.00
AC:
0
AN:
24845
South Asian (SAS)
AF:
0.000152
AC:
7
AN:
46151
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
35015
Middle Eastern (MID)
AF:
0.000381
AC:
1
AN:
2622
European-Non Finnish (NFE)
AF:
0.0000398
AC:
31
AN:
779609
Other (OTH)
AF:
0.00325
AC:
134
AN:
41213
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
49
98
148
197
246
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00789
AC:
376
AN:
47676
Hom.:
9
Cov.:
8
AF XY:
0.00821
AC XY:
37
AN XY:
4506
show subpopulations
African (AFR)
AF:
0.0305
AC:
353
AN:
11571
American (AMR)
AF:
0.00383
AC:
16
AN:
4178
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
1272
East Asian (EAS)
AF:
0.00
AC:
0
AN:
1531
South Asian (SAS)
AF:
0.00
AC:
0
AN:
670
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
2418
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
83
European-Non Finnish (NFE)
AF:
0.000160
AC:
4
AN:
25024
Other (OTH)
AF:
0.00458
AC:
3
AN:
655
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.557
Heterozygous variant carriers
0
15
31
46
62
77
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00188
Hom.:
32
ESP6500AA
AF:
0.0351
AC:
114
ESP6500EA
AF:
0.000539
AC:
3
ExAC
AF:
0.00407
AC:
136

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

not provided Benign:3
Jul 14, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Aug 28, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Sep 24, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Primary ciliary dyskinesia Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

RPGR-related retinopathy Benign:1
Sep 05, 2025
ClinGen X-linked Inherited Retinal Disease Variant Curation Expert Panel, ClinGen
Significance:Benign
Review Status:reviewed by expert panel
Collection Method:curation

NM_001034853.2(RPGR):c.2411G>A (p.Arg804Lys) is a missense variant predicted to cause substitution of arginine by lysine at amino acid 804. This variant is present in gnomAD v4.1.0 at a frequency of 0.001070 among hemizygous individuals, with 334 variant alleles / 312,147 total hemizygous alleles, which is higher than the ClinGen X-linked IRD VCEP BA1 threshold of >0.00005 (BA1). The computational predictor REVEL gives a score of 0.011, which is below the ClinGen X-linked IRD VCEP threshold of <0.016 and predicts a non-damaging effect on RPGR function. Additionally, the splicing impact predictor SpliceAI gives a delta score of 0, which is below the ClinGen X-linked IRD VCEP recommended threshold of <0.2 and does not strongly predict an impact on splicing (BP4_Strong). In summary, this variant is classified as benign for RPGR-related retinopathy based on the ClinGen X-linked Inherited Retinal Disease Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for RPGR Version 1.0.0; BA1 and BP4_Strong.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.063
BayesDel_addAF
Benign
-1.0
T
BayesDel_noAF
Benign
-1.2
CADD
Benign
0.0030
DANN
Benign
0.44
FATHMM_MKL
Benign
0.0010
N
LIST_S2
Benign
0.25
T
MetaRNN
Benign
0.0029
T
MetaSVM
Benign
-0.92
T
PhyloP100
-1.2
PrimateAI
Benign
0.20
T
PROVEAN
Benign
0.23
N
REVEL
Benign
0.011
Sift4G
Benign
1.0
T
Vest4
0.031
MVP
0.10
MPC
0.79
ClinPred
0.0015
T
GERP RS
-0.92
gMVP
0.0024
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs147388235; hg19: chrX-38145841; API